BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37925632)

  • 1. Protocol for isolation of signet ring cells from human gastric mucosa.
    Samaranayake SG; Gamble LA; Bowden C; Green BL; Gallanis AF; Akbulut D; Shah N; Hernandez JM; Davis JL
    STAR Protoc; 2023 Dec; 4(4):102695. PubMed ID: 37925632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications.
    Rogers WM; Dobo E; Norton JA; Van Dam J; Jeffrey RB; Huntsman DG; Kingham K; Chun N; Ford JM; Longacre TA
    Am J Surg Pathol; 2008 Jun; 32(6):799-809. PubMed ID: 18391748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary diffuse gastric cancer: a manifestation of lost cell polarity.
    Humar B; Guilford P
    Cancer Sci; 2009 Jul; 100(7):1151-7. PubMed ID: 19432899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary diffuse gastric cancer: predominance of multiple foci of signet ring cell carcinoma in distal stomach and transitional zone.
    Charlton A; Blair V; Shaw D; Parry S; Guilford P; Martin IG
    Gut; 2004 Jun; 53(6):814-20. PubMed ID: 15138207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at risk.
    Barber ME; Save V; Carneiro F; Dwerryhouse S; Lao-Sirieix P; Hardwick RH; Caldas C; Fitzgerald RC
    J Pathol; 2008 Nov; 216(3):286-94. PubMed ID: 18825658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological features of total gastrectomy specimens from asymptomatic hereditary diffuse gastric cancer patients and implications for clinical management.
    Rocha JP; Gullo I; Wen X; Devezas V; Baptista M; Oliveira C; Carneiro F
    Histopathology; 2018 Dec; 73(6):878-886. PubMed ID: 30014492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic surveillance with systematic random biopsy for the early diagnosis of hereditary diffuse gastric cancer: a prospective 16-year longitudinal cohort study.
    Lee CYC; Olivier A; Honing J; Lydon AM; Richardson S; O'Donovan M; Tischkowitz M; Fitzgerald RC; di Pietro M
    Lancet Oncol; 2023 Jan; 24(1):107-116. PubMed ID: 36509094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Hereditary Lobular Breast Cancer Due to CDH1 Variants and Gastric Cancer Risk.
    Gamble LA; Rossi A; Fasaye GA; Kesserwan C; Hernandez JM; Blakely AM; Davis JL
    JAMA Surg; 2022 Jan; 157(1):18-22. PubMed ID: 34643667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathologic Analysis of Signet-ring Cell Carcinoma In Situ in Patients With Hereditary Diffuse Gastric Cancer.
    Tsugeno Y; Nakano K; Nakajima T; Namikawa K; Takamatsu M; Yamamoto N; Fujisaki J; Nunobe S; Kitagawa M; Takeuchi K; Kawachi H
    Am J Surg Pathol; 2020 Sep; 44(9):1204-1212. PubMed ID: 32520759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of endoscopic surveillance in hereditary diffuse gastric cancer according to CDH1 mutation status.
    Mi EZ; Mi EZ; di Pietro M; O'Donovan M; Hardwick RH; Richardson S; Ziauddeen H; Fletcher PC; Caldas C; Tischkowitz M; Ragunath K; Fitzgerald RC
    Gastrointest Endosc; 2018 Feb; 87(2):408-418. PubMed ID: 28688938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of screening gastroscopy in first-degree relatives of patients fulfilling hereditary diffuse gastric cancer criteria.
    van der Post RS; van Dieren J; Grelack A; Hoogerbrugge N; van der Kolk LE; Snaebjornsson P; Lansdorp-Vogelaar I; van Krieken JH; Bisseling TM; Cats A
    Gastrointest Endosc; 2018 Feb; 87(2):397-404.e2. PubMed ID: 28455161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic analysis of a case of Helicobacter pylori-uninfected intramucosal gastric cancer in a family with hereditary diffuse gastric cancer.
    Funakoshi T; Miyamoto S; Kakiuchi N; Nikaido M; Setoyama T; Yokoyama A; Horimatsu T; Yamada A; Torishima M; Kosugi S; Yamada H; Sugimura H; Haga H; Sakai Y; Ogawa S; Seno H; Muto M; Chiba T
    Gastric Cancer; 2019 Jul; 22(4):892-898. PubMed ID: 30542785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary gastric cancer.
    Carneiro F
    Pathologe; 2012 Nov; 33 Suppl 2():231-4. PubMed ID: 23052347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of Endoscopic Surveillance in Individuals With Genetic Predisposition to Hereditary Diffuse Gastric Cancer.
    Jacobs MF; Dust H; Koeppe E; Wong S; Mulholland M; Choi EY; Appelman H; Stoffel EM
    Gastroenterology; 2019 Jul; 157(1):87-96. PubMed ID: 30935944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Immune Changes Support Signet Ring Cell Dormancy in CDH1-Driven Hereditary Diffuse Gastric Carcinogenesis.
    Green BL; Gamble LA; Diggs LP; Nousome D; Patterson JC; Joughin BA; Gasmi B; Lux SC; Samaranayake SG; Miettinen M; Quezado M; Hernandez JM; Yaffe MB; Davis JL
    Mol Cancer Res; 2023 Dec; 21(12):1356-1365. PubMed ID: 37707375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indications for Total Gastrectomy in CDH1 Mutation Carriers and Outcomes of Risk-Reducing Minimally Invasive and Open Gastrectomies.
    Vos EL; Salo-Mullen EE; Tang LH; Schattner M; Yoon SS; Gerdes H; Markowitz AJ; Mandelker D; Janjigian Y; Offitt K; Coit DG; Stadler ZK; Strong VE
    JAMA Surg; 2020 Nov; 155(11):1050-1057. PubMed ID: 32997132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histologic and immunohistochemical differences between hereditary and sporadic diffuse gastric carcinoma.
    Lee HE; Smyrk TC; Zhang L
    Hum Pathol; 2018 Apr; 74():64-72. PubMed ID: 29307626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary diffuse gastric cancer: translation of CDH1 germline mutations into clinical practice.
    Guilford P; Humar B; Blair V
    Gastric Cancer; 2010 Mar; 13(1):1-10. PubMed ID: 20373070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective cohort study assessing outcomes of patients from families fulfilling criteria for hereditary diffuse gastric cancer undergoing endoscopic surveillance.
    Lim YC; di Pietro M; O'Donovan M; Richardson S; Debiram I; Dwerryhouse S; Hardwick RH; Tischkowitz M; Caldas C; Ragunath K; Fitzgerald RC
    Gastrointest Endosc; 2014 Jul; 80(1):78-87. PubMed ID: 24472763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary Diffuse Gastric Cancer Treated by Prophylactic Total Gastrectomy.
    Inaba Y; Goda K; Kondo M; Abe K; Kanamori A; Suzuki T; Tominaga K; Nakagawa M; Morita S; Kojima K; Ishida K; Irisawa A
    Intern Med; 2024 Jan; 63(2):235-239. PubMed ID: 37225495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.